Notably, BAFF increased relative CLL cell viability in vitro also in the absence of small molecule inhibitors, which is in accordance with findings reported by Novak et al. [33] (Figure 1C). Here, TNFSF13B is linked to B-cell chronic lymphocytic leukemia.